These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21864628)
1. Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax. Baylor NW Vaccine; 2011 Nov; 29(48):8771; author reply 8772. PubMed ID: 21864628 [No Abstract] [Full Text] [Related]
2. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Wyman MJ; Stabi KL Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069 [TBL] [Abstract][Full Text] [Related]
3. Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine. Bruxvoort K; Sy LS; Luo Y; Tseng HF Am J Epidemiol; 2018 Sep; 187(9):1856-1862. PubMed ID: 29659663 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Tseng HF; Smith N; Sy LS; Jacobsen SJ Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407 [TBL] [Abstract][Full Text] [Related]
5. Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Oxman MN; Gershon AA; Poland GA Vaccine; 2011 May; 29(20):3625-7. PubMed ID: 21524565 [No Abstract] [Full Text] [Related]
11. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies. Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial. Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381 [TBL] [Abstract][Full Text] [Related]
13. Varicella virus and the herpes zoster vaccine. A review of Zostavax and the new AFIP recommendations. Ebede TL; Zippin JH J Drugs Dermatol; 2008 Dec; 7(12):1173-6. PubMed ID: 19137773 [No Abstract] [Full Text] [Related]
14. [Shingles vaccine: which recommendations in 2014?]. Vionnet J; Hart K; Spertini F Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646 [TBL] [Abstract][Full Text] [Related]
15. Herpes zoster vaccine. Poorly effective in those who need it most. Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094 [TBL] [Abstract][Full Text] [Related]
16. Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations. ; Husein N; Chetty A Can J Diabetes; 2018 Apr; 42 Suppl 1():S142-S144. PubMed ID: 29650086 [No Abstract] [Full Text] [Related]
17. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination. Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488 [TBL] [Abstract][Full Text] [Related]
18. FDA expands age range for shingles vaccine. Voelker R JAMA; 2011 Apr; 305(15):1526. PubMed ID: 21505126 [No Abstract] [Full Text] [Related]